Bill Would Allow Price Negotiation, Encourage Medicare Generics Use

The Centers for Medicare & Medicaid Services would gain the right to negotiate prices for Medicare Part D drugs directly with pharmaceutical companies and potentially increase the use of generics if a new bill becomes law. Drugmakers pushed for Congress to add a provision to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 that kept the agency from negotiating lower prices, said Rep. Jan Schakowsky (D-Ill.), a sponsor of H.R. 684, the Medicare Prescription Drug Savings and Choice Act of 2009.
Generic Line